The Medicines and Healthcare products Regulatory Agency (MHRA) has suspended the licence of levothyroxine 100 microgram tablets, manufactured by Teva, for patients with hypothyroidism. This follows manufacturing difficulties and concerns that the product might not be interchangeable with other available levothyroxine 100 mcg tablets. This may lead to a loss of control of hypothyroidism when switching between products.
More...
News from The Operating Theatre Journal
Jobs from Operating Theatre Jobs dotcom
Sunday, 19 February 2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment